Principal Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$616M Sell
2,831,636
-36,970
-1% -$8.2M 0.33% 62
2025
Q4
$655M Sell
2,868,606
-482
-0% -$110K 0.33% 64
2025
Q3
$664M Buy
2,869,088
+220,950
+8% +$45M 0.34% 60
2025
Q2
$492M Buy
2,648,138
+32,673
+1% +$6.07M 0.26% 82
2025
Q1
$548M Buy
2,615,465
+149,662
+6% +$29.1M 0.31% 71
2024
Q4
$438M Sell
2,465,803
-21,560
-0.9% -$3.96M 0.24% 85
2024
Q3
$491M Buy
2,487,363
+273,078
+12% +$51M 0.27% 83
2024
Q2
$380M Sell
2,214,285
-39,892
-2% -$6.61M 0.23% 95
2024
Q1
$410M Sell
2,254,177
-33,121
-1% -$5.71M 0.24% 94
2023
Q4
$354M Buy
2,287,298
+23,991
+1% +$3.5M 0.23% 101
2023
Q3
$337M Sell
2,263,307
-17,692
-0.8% -$2.6M 0.24% 95
2023
Q2
$307M Sell
2,280,999
-81,998
-3% -$12M 0.21% 111
2023
Q1
$377M Buy
2,362,997
+12,409
+0.5% +$1.9M 0.27% 97
2022
Q4
$380M Buy
2,350,588
+29,779
+1% +$4.57M 0.29% 94
2022
Q3
$311M Sell
2,320,809
-98,703
-4% -$14.2M 0.25% 101
2022
Q2
$371M Sell
2,419,512
-64,974
-3% -$9.93M 0.27% 88
2022
Q1
$403M Sell
2,484,486
-27,139
-1% -$3.94M 0.25% 101
2021
Q4
$340M Sell
2,511,625
-66,165
-3% -$7.82M 0.2% 130
2021
Q3
$278M Sell
2,577,790
-70,716
-3% -$8.08M 0.18% 143
2021
Q2
$298M Sell
2,648,506
-29,499
-1% -$3.32M 0.19% 130
2021
Q1
$290M Sell
2,678,005
-178,098
-6% -$19M 0.2% 126
2020
Q4
$306M Buy
2,856,103
+329,852
+13% +$31.7M 0.23% 116
2020
Q3
$221M Sell
2,526,251
-187,440
-7% -$17.6M 0.19% 136
2020
Q2
$266M Buy
2,713,691
+558,412
+26% +$49.2M 0.23% 115
2020
Q1
$164M Sell
2,155,279
-8,688
-0.4% -$740K 0.18% 147
2019
Q4
$192M Sell
2,163,967
-229,604
-10% -$19.1M 0.16% 173
2019
Q3
$181M Sell
2,393,571
-39,108
-2% -$2.68M 0.16% 164
2019
Q2
$177M Buy
2,432,679
+73,929
+3% +$5.81M 0.16% 160
2019
Q1
$190M Sell
2,358,750
-49,248
-2% -$4.03M 0.18% 138
2018
Q4
$222M Sell
2,407,998
-272,938
-10% -$24M 0.24% 103
2018
Q3
$254M Buy
2,680,936
+693
+0% +$65.7K 0.22% 109
2018
Q2
$248M Sell
2,680,243
-221,062
-8% -$21.6M 0.23% 104
2018
Q1
$275M Sell
2,901,305
-61,380
-2% -$6.74M 0.26% 91
2017
Q4
$287M Sell
2,962,685
-346,721
-10% -$32.7M 0.26% 91
2017
Q3
$294M Sell
3,309,406
-202,826
-6% -$15.4M 0.29% 82
2017
Q2
$255M Sell
3,512,232
-17,587
-0.5% -$1.18M 0.26% 94
2017
Q1
$230M Buy
3,529,819
+145,904
+4% +$9.17M 0.28% 92
2016
Q4
$212M Sell
3,383,915
-86,852
-3% -$5.3M 0.27% 89
2016
Q3
$219M Buy
3,470,767
+44,361
+1% +$2.87M 0.29% 82
2016
Q2
$212M Sell
3,426,406
-33,126
-1% -$2.02M 0.3% 86
2016
Q1
$198M Buy
3,459,532
+956,194
+38% +$53.3M 0.29% 89
2015
Q4
$148M Buy
2,503,338
+61,979
+3% +$3.57M 0.22% 126
2015
Q3
$133M Sell
2,441,359
-111,112
-4% -$7.23M 0.21% 134
2015
Q2
$172M Buy
2,552,471
+36,298
+1% +$2.37M 0.26% 110
2015
Q1
$147M Sell
2,516,173
-5,405
-0.2% -$327K 0.22% 130
2014
Q4
$165M Sell
2,521,578
-1,632,764
-39% -$103M 0.26% 107
2014
Q3
$240M Buy
4,154,342
+92,493
+2% +$5.14M 0.41% 43
2014
Q2
$229M Sell
4,061,849
-330,209
-8% -$17.3M 0.39% 45
2014
Q1
$226M Buy
4,392,058
+249,445
+6% +$12.6M 0.4% 37
2013
Q4
$219M Sell
4,142,613
-381,115
-8% -$18.7M 0.41% 35
2013
Q3
$202M Buy
4,523,728
+43,225
+1% +$1.92M 0.42% 36
2013
Q2
$185M Buy
+4,480,503
New +$196M 0.41% 36

Other funds holding ABBV

Principal Financial Group's ABBV Position: Q1 2026 in Review

Principal Financial Group reduced its AbbVie (ABBV) stake by 1.3% in Q1 2026, selling an estimated $8.2M and leaving 2,831,636 shares worth $616M. The position accounts for 0.33% of the portfolio, ranked #62.

Principal Financial Group first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $664M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Principal Financial Group held 2,831,636 shares of AbbVie worth $616M as of Q1 2026.
  • Principal Financial Group sold 36,970 AbbVie shares in Q1 2026, an estimated $8.2M.
  • AbbVie made up 0.33% of Principal Financial Group's portfolio in Q1 2026, its #62 holding.
  • Principal Financial Group first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Principal Financial Group's AbbVie position peaked at $664M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.